- Home
- CTVA vs GEHC Comparison
CTVA vs GEHC Comparison
Compare CTVA & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTVA
- GEHC
- Stock Information
- Founded
- CTVA 2018
- GEHC 1892
- Country
- CTVA United States
- GEHC United States
- Employees
- CTVA N/A
- GEHC N/A
- Industry
- CTVA Farming/Seeds/Milling
- GEHC Computer Software: Prepackaged Software
- Sector
- CTVA Consumer Staples
- GEHC Technology
- Exchange
- CTVA Nasdaq
- GEHC Nasdaq
- Market Cap
- CTVA 44.9B
- GEHC 37.5B
- IPO Year
- CTVA N/A
- GEHC N/A
- Fundamental
- Price
- CTVA $63.97
- GEHC $79.36
- Analyst Decision
- CTVA Strong Buy
- GEHC Buy
- Analyst Count
- CTVA 16
- GEHC 12
- Target Price
- CTVA $68.06
- GEHC $98.75
- AVG Volume (30 Days)
- CTVA 3.4M
- GEHC 3.4M
- Earning Date
- CTVA 05-07-2025
- GEHC 04-29-2025
- Dividend Yield
- CTVA 1.07%
- GEHC 0.18%
- EPS Growth
- CTVA 26.57
- GEHC 43.17
- EPS
- CTVA 1.30
- GEHC 4.34
- Revenue
- CTVA $16,908,000,000.00
- GEHC $19,672,000,000.00
- Revenue This Year
- CTVA $4.27
- GEHC $3.77
- Revenue Next Year
- CTVA $3.44
- GEHC $4.72
- P/E Ratio
- CTVA $48.96
- GEHC $18.29
- Revenue Growth
- CTVA N/A
- GEHC 0.61
- 52 Week Low
- CTVA $50.01
- GEHC $74.51
- 52 Week High
- CTVA $66.24
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- CTVA 60.55
- GEHC 33.48
- Support Level
- CTVA $60.72
- GEHC $79.20
- Resistance Level
- CTVA $63.13
- GEHC $82.89
- Average True Range (ATR)
- CTVA 1.22
- GEHC 1.52
- MACD
- CTVA 0.32
- GEHC -0.16
- Stochastic Oscillator
- CTVA 98.86
- GEHC 15.73
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).